OVERVIEW
The site bionta.cn presently has an average traffic ranking of zero (the lower the more traffic).
BIONTA.CN TRAFFIC
The site bionta.cn is seeing diverging levels of traffic throughout the the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
LINKS TO DOMAIN
WHAT DOES BIONTA.CN LOOK LIKE?
BIONTA.CN SERVER
We revealed that a single page on bionta.cn took one thousand six hundred and sixty-six milliseconds to come up. We could not discover a SSL certificate, so I consider this site not secure.
Load time
1.666 secs
SSL
NOT SECURE
Internet Protocol
116.213.144.73
BROWSER IMAGE
SERVER OS
We discovered that bionta.cn is utilizing the *********** operating system.HTML TITLE
北京市新技术应用研究所DESCRIPTION
属于北京市科学技术研究院是一个集科研开发生产于一体的高新技术企业主要在电子信息生物医药新材料光机电一体化环保节能领域开展新产品新设备的科研和开发PARSED CONTENT
The site has the following on the web page, "河南网通-2x8 Overview cDR 80-DL TransForm A2006." We noticed that the web site also said " 云南电力调度中心-2x9 Overview cDR 80-DL TransForm A2006." It also stated " 深圳电力-2x7 Overview cDG80-DL TransForm A2007. 版权所有 北京市新技术应用研究所 All Right Reserved." The header had 模式识别 as the highest ranking keyword. This keyword was followed by 生物识别, 公共安全, and 实验仪器 which isn't as urgent as 模式识别. The other words the site uses is 北京市新技术应用研究所.ANALYZE MORE BUSINESSES
Bionic Composite Technologies AG - Hochwertige Faserverbundbauteile
Carbon Serienfertigung in neuer Dimension. Carbon Serienfertigung in neuer Dimension. Carbon Serienfertigung in neuer Dimension. Carbon Serienfertigung in neuer Dimension. Ohne Verschwendung, ganz wie in der Natur. BIONTEC vereinigt über 150 Jahre textiles Wissen mit einem umfassenden Know-how in der.
Home - BioNTech
MEDICINE AS UNIQUE AS YOU. Medicines as Unique as You. We are developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases. BioNTech Secures USD 270 Million in Series A Financing. BioNTech to Present at 36th Annual J. BioNTech AG Enters into Licensing Agreement with CELLSCRIPT.